Drugs / DTPa-HBV-IPV/Hib
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00289796 Comparator | Jul 2004 → Apr 2006 | hepatitis B virus infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTPa-HBV-IPV/Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00289796 ↗ |
| Known as | Infanrix Hexa | “GSK Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib Vaccine)” NCT00289796 ↗ |
| Modality | Vaccine | “conjugate vaccine” NCT00289796 ↗ |
| Route | Intramuscular | “deep intramuscular injection” NCT00289796 ↗ |